Skip to main content
. Author manuscript; available in PMC: 2011 May 18.
Published in final edited form as: Cancer Cell. 2010 Apr 15;17(5):510–522. doi: 10.1016/j.ccr.2010.03.017

Table 1. G-CIMP and IDH1 mutation status in primary, secondary, and recurrent GBMs.

G-CIMP and IDH1 mutation status are compared for All analyzed GBM tumors (p< 2.2x10−16), Primary tumors, Recurrent tumors, and Secondary tumors. P value is calculated from Fisher’s exact test. See also Figure S3 and Table S2.

ALL TUMORS G-CIMP TOTAL
+
IDH1 Wild-type 184 5 189
Mutant 0 18 18
TOTAL 184 23 207
PRIMARY TUMORS G-CIMP TOTAL
+
IDH1 Wild-type 171 4 175
Mutant 0 12 12
TOTAL 171 16 187
RECURRENT TUMORS G-CIMP TOTAL
+
IDH1 Wild-type 12 0 12
Mutant 0 4 4
TOTAL 12 4 16
SECONDARY G-CIMP TOTAL
TUMORS +
IDH1 Wild-type 1 1 2
Mutant 0 2 2
TOTAL 1 3 4